1.
|
Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: Protocol IDs: MSKCC-88143, NCI-V89-0039
|
|
2.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-07-C-0047, NCI-P6880, NCT00436735
|
|
3.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 to 65 Sponsor: Pharmaceutical / Industry Protocol IDs: NP22676, NCT01001299
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MK-8669-044, 2010_511, NCT01071304
|
|
5.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 12434, NCT01287598
|
|
6.
|
Phase: No phase specified Type: Supportive care Status: Completed Age: 18 and over Sponsor: Protocol IDs: MSKCC-89098, NCI-V89-0193
|
|
7.
|
Phase: No phase specified Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 07-000848, NCT00578214
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: WCCC-CO-09908, CO09908, 8516, NCT01218620
|